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ABSTRACT 
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk 
assessments carried out by the competent authority of the rapporteur Member State Italy, for the pesticide active 
substance Bacillus thuringiensis israelensis AM65-52 are reported.  The context of the peer review was that 
required by Commission Regulation (EC) No 2229/2004, as amended by Commission Regulation (EC) No 
1095/2007. The conclusions were reached on the basis of the evaluation of the representative uses of Bacillus 
thuringiensis israelensis AM65-52 as an insecticide on ornamentals. The reliable endpoints concluded as being 
appropriate for use in regulatory risk assessment, derived from the available studies and literature in the dossier 
peer reviewed, are presented. Missing information identified as being required by the regulatory framework is 
listed. Concerns are identified.  
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SUMMARY 
Bacillus thuringiensis israelensis AM65-52 is one of the 295 substances of the fourth stage of the 
review programme covered by Commission Regulation (EC) No 2229/2004, as amended by 
Commission Regulation (EC) No 1095/2007. 
Bacillus thuringiensis israelensis AM65-52 was included in Annex I to Directive 91/414/EEC on 8 
December 2008 pursuant to Article 24b of the Regulation (EC) No 2229/2004 (hereinafter referred to 
as ‘the Regulation’) and has subsequently been deemed to be approved under Regulation (EC) No 
1107/2009, in accordance with Commission Implementing Regulation (EU) No 540/2011, as amended 
by Commission Implementing Regulation (EU) No 541/2011. In accordance with Article 25a of the 
Regulation, as amended by Commission Regulation (EU) No 114/2010, the European Food Safety 
Authority (EFSA) is required to deliver by 31 December 2012 its view on the draft review report 
submitted by the European Commission in accordance with Article 25(1) of the Regulation. This 
review report was established as a result of the initial evaluation provided by the designated rapporteur 
Member State in the Draft Assessment Report (DAR). The EFSA therefore organised a peer review of 
the DAR. The conclusions of the peer review are set out in this report. 
Italy being the designated rapporteur Member State submitted the DAR on Bacillus thuringiensis 
israelensis AM65-52 in accordance with the provisions of Article 22(1) of the Regulation, which was 
received by the EFSA on 28 November 2007. The peer review was initiated on 18 April 2008 by 
dispatching the DAR for consultation of the notifier Sumitomo Chemical Agro Europe SAWS. 
Subsequently the DAR was distributed on 11 June 2008 for consultation of the Member States. 
Following consideration of the comments received on the DAR, it was concluded that there was no 
need to conduct an expert consultation and EFSA should deliver its conclusions on Bacillus 
thuringiensis israelensis AM65-52. 
The conclusions laid down in this report were reached on the basis of the evaluation of the 
representative uses of Bacillus thuringiensis israelensis AM65-52  as an insecticide on ornamentals as 
proposed by the notifier. Full details of the representative uses can be found in Appendix A to this 
report. 
In the area of identity of the micro-organism/biological properties/physical and technical properties 
and methods of analysis the main data gaps are related to contaminating microorganisms, method for 
parasporal body protein, identification method, method of analysis for contaminating microorganisms, 
method for the microorganism, biopotency method, optimal environmental growing conditions and the 
temperature range of growth, validation of the methods for the toxins and validation for the method for 
the CFU in the formulation. 
In the area of mammalian toxicology, two data gaps were identified. The first one is related to the 
production of toxins after application, and the risk assessment cannot be finalised for humans that 
might be exposed to these toxins (e.g. re-entry workers). The second one is related to the validation of 
the bridging of toxicological data between the formulation VectoBac 12 AS (of unknown 
composition) and the representative formulation VectoBac WDG. 
The only use for this organism is on ornamentals and no edible crops will be treated, therefore a 
consumer risk assessment is not necessary. 
No information has been provided in relation to potential interferences of Bacillus thuringiensis with 
the analytical systems for the control of the quality of drinking water provided for in Directive 
98/83/EC. No information has been provided on the potential transfer of genetic material from 
Bacillus thuringiensis to other organisms. Data gaps have been identified and these issues cannot be 
finalized. The original scientific papers quoted in the fate section of the dossier have not been 
provided. Therefore, a data gap has been identified. During the peer review a data gap was identified 
for the groundwater exposure assessment of the crystalline proteins and conversion products that Peer review of the pesticide risk assessment of the active substance 
Bacillus thuringiensis israelensis AM65-52
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retain any insecticidal activity. Nevertheless, since only uses in greenhouse on potted plants are 
intended, adequate management to prevent natural soil and groundwater contamination may be 
proposed in absence of further information.  
A data gap was identified in the Ecotoxicology section i.e. to provide information as regards the risk to 
biological methods for sewage treatment plants.  
 
 Peer review of the pesticide risk assessment of the active substance 
Bacillus thuringiensis israelensis AM65-52
 
EFSA Journal 2013;11(4):3054    4
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 4 
Background .............................................................................................................................................. 5 
The active substance and the formulated product .................................................................................... 7 
The identity of the microorganism and the properties of the formulated product .................................... 7 
Conclusions of the evaluation .................................................................................................................. 7 
1.  Identity of the microorganism/biological properties/physical and technical properties and 
methods of analysis. ................................................................................................................................. 7 
2.  Mammalian toxicity  ......................................................................................................................... 7 
3.  Residues ........................................................................................................................................... 9 
4.  Environmental fate and behaviour ................................................................................................... 9 
4.1.  Fate and behaviour in the environment of the microorganism ............................................... 9 
4.2.  Fate and behaviour in the environment of any relevant metabolite formed by the 
microorganism under relevant environmental conditions .................................................................. 10 
5.  Ecotoxicology ................................................................................................................................ 11 
6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment 
of effects data for the environmental compartments .............................................................................. 12 
6.1.  Soil ........................................................................................................................................ 12 
6.2.  Ground water ........................................................................................................................ 12 
6.3.  Surface water and sediment .................................................................................................. 12 
6.4.  Air ......................................................................................................................................... 13 
7.  List of studies to be generated, still ongoing or available but not peer reviewed .......................... 14 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified  ............. 15 
9.  Concerns ........................................................................................................................................ 15 
9.1.  Issues that could not be finalised .......................................................................................... 15 
9.2.  Critical areas of concern ....................................................................................................... 16 
9.3.  Overview of the concerns identified for each representative use considered ....................... 16 
References .............................................................................................................................................. 18 
Appendices ............................................................................................................................................. 19 
Abbreviations ......................................................................................................................................... 34 Peer review of the pesticide risk assessment of the active substance 
Bacillus thuringiensis israelensis AM65-52
 
EFSA Journal 2013;11(4):3054    5
BACKGROUND 
Bacillus thuringiensis israelensis AM65-52 is one of the 295 substances of the fourth stage of the 
review programme covered by Commission Regulation (EC) No 2229/2004,
3 as amended by 
Commission Regulation (EC) No 1095/2007.
4 
Bacillus thuringiensis israelensis AM65-52 was included in Annex I to Directive 91/414/EEC
5 on 8 
December 2008 pursuant to Article 24b of the Regulation (EC) No 2229/2004 (hereinafter referred to 
as ‘the Regulation’) and has subsequently been deemed to be approved under Regulation (EC) No 
1107/2009,
6 in accordance with Commission Implementing Regulation (EU) No 540/2011,
7 as 
amended by Commission Implementing Regulation (EU) No 541/2011.
8 In accordance with Article 
25a of the Regulation, as amended by Commission Regulation (EU) No 114/2010
9 the European Food 
Safety Authority (EFSA) is required to deliver by 31 December 2012 its view on the draft review 
report submitted by the European Commission in accordance with Article 25(1) of the Regulation 
(European Commission, 2008). This review report was established as a result of the initial evaluation 
provided by the designated rapporteur Member State in the Draft Assessment Report (DAR). The 
EFSA therefore organised a peer review of the DAR. The conclusions of the peer review are set out in 
this report. 
Italy being the designated rapporteur Member State submitted the DAR on Bacillus thuringiensis 
israelensis AM65-52 in accordance with the provisions of Article 22(1) of the Regulation, which was 
received by the EFSA on 28 November 2007 (Italy, 2007). The peer review was initiated on 18 April 
2008 by dispatching the DAR for consultation of the notifier Sumitomo Chemical Agro Europe SAS. 
Subsequently the DAR was distributed on 11 June 2008 for consultation of the Member States. In 
addition, the EFSA conducted a public consultation on the DAR. The comments received were 
collated by the EFSA and forwarded to the RMS for compilation and evaluation in the format of a 
Reporting Table. The comments were evaluated by the RMS in column 3 of the Reporting Table. 
The scope of the peer review was considered in a telephone conference between the EFSA, the RMS, 
and the European Commission on 22 June 2012. On the basis of the comments received and the RMS’ 
evaluation thereof it was concluded that there was no need to conduct an expert consultation. 
The outcome of the telephone conference, together with EFSA’s further consideration of the 
comments is reflected in the conclusions set out in column 4 of the Reporting Table. All points that 
were identified as unresolved at the end of the comment evaluation phase and which required further 
consideration, and additional information to be submitted by the notifier, were compiled by the EFSA 
                                                      
3 Commission Regulation (EC) No 2229/2004 of 3 December 2004 laying down further detailed rules for the implementation 
of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC. OJ L 379, 
24.12.2004, p.13-63. 
4 Commission Regulation (EC) No 1095/2007 of 20 September 2007 amending Regulation (EC) No 1490/2002 laying down 
further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of 
Council Directive 91/414/EEC and Regulation (EC) No 2229/2004 laying down further detailed rules for the implementation 
of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC. OJ L 246, 
21.9.2007, p.19-28. 
5 Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 
19.8.1991, p. 1-32, as last amended.  
6 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ L 309, 
24.11.2009, p.1-50. 
7 Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of 
the European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p.1-186. 
8 Commission Implementing Regulation (EU) No 541/2011 of 1 June 2011 amending Implementing Regulation (EU) No 
540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of 
approved active substances. OJ L 153, 11.6.2011, p.187-188. 
9 Commission Regulation (EU) No 114/2010 of 9 February 2010 amending Regulation (EC) No 2229/2004 as regards the 
time period granted to EFSA for the delivery of its view on the draft review reports concerning the active substances for 
which there are clear indications that they do not have any harmful effects. OJ L 37, 10.2.2010, p.12. Peer review of the pesticide risk assessment of the active substance 
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in the format of an Evaluation Table. The notifier was invited to respond to the comments in column 2 
of the Evaluation Table.  
The conclusions arising from the consideration by the EFSA, and as appropriate by the RMS, of the 
points identified in the Evaluation Table, together with the outcome of the expert discussions where 
these took place, were reported in the final column of the Evaluation Table. 
A final consultation on the conclusions arising from the peer review of the risk assessment took place 
with Member States via a written procedure in November 2012. 
This conclusion report summarises the outcome of the peer review of the risk assessment on the active 
substance and the representative formulation evaluated on the basis of the representative uses as a 
insecticide on ornamentals, as proposed by the notifier. A list of the relevant end points for the active 
substance as well as the formulation is provided in Appendix A. In addition, a key supporting 
document to this conclusion is the Peer Review Report, which is a compilation of the documentation 
developed to evaluate and address all issues raised in the peer review, from the initial commenting 
phase to the conclusion. The Peer Review Report (EFSA, 2012) comprises the following documents, 
in which all views expressed during the course of the peer review, including minority views, can be 
found: 
•  the comments received on the DAR, 
•  the Reporting Table (20 July 2009)  
•  the Evaluation Table (10 December 2012) 
•  the report(s) of the scientific consultation with Member State experts (where relevant), 
•  the comments received on the draft EFSA conclusion.  
Given the importance of the DAR including its addendum (compiled version of November 2012 
containing all individually submitted addenda (Italy, 2012)) and the Peer Review Report, both 
documents are considered respectively as background documents A and B to this conclusion.  
  Peer review of the pesticide risk assessment of the active substance 
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THE ACTIVE SUBSTANCE AND THE FORMULATED PRODUCT 
THE IDENTITY OF THE MICROORGANISM AND THE PROPERTIES OF THE FORMULATED 
PRODUCT 
Bacillus thuringiensis subsp. israelensis strain AM65-52 was isolated from mosquito larvae in Israel.  
The representative formulation evaluated is ‘VectoBac WG’. The formulation contains approximately 
374 g/kg fermentation solids and soluble. This gives approximately 3 x 10
9 CFU/g 
The representative use evaluated is on ornamentals as a foliar spray to control fungus gnats Diptera 
Sciaridae. Full details of the GAP can be found in the list of end points in Appendix A. 
CONCLUSIONS OF THE EVALUATION 
1.  Identity of the microorganism/biological properties/physical and technical properties 
and methods of analysis. 
The production culture of Bacillus thuringiensis subsp. israelensis strain AM65-52, has been placed in 
the American Type Culture Collection under the accession number ATCC – 1276. 
The strain is not a human pathogen but it is related to human pathogens. A data gap was identified for 
its growth temperature range as well as the optimal growing conditions. 
It has been demonstated that this strain does not produce significant quantities of enterotoxins, β-
exotoxin and cytolytic proteins in the production process. The content of contaminating micro-
organisms was not fully addressed and a data gap was identified. 
A method of analysis to unequivocally identify the organism down to strain level was not available to 
the peer review. All the methods of analysis were not validated for the strain, contaminating and 
pathogenic micro-organisms and further validation is needed for the method for the toxins.  
Methods of analysis for products of plant and animal origin are not necessary as there are no edible 
crop uses.  Methods of analysis for body fluids and tissues are not required as there is no classification 
for toxic or very toxic. 
Environmental methods of analysis may be required in the future once the outstanding environmental 
data issues have been addressed. 
It should be noted that during the shelf-life study there is a 20 % decrease in potency after the two year 
storage period. 
2.  Mammalian toxicity 
Medical data and sensitisation 
Epidemiological data specific to Bacillus thuringiensis subsp. israelensis AM65-52 were not provided 
in the dossier. No adverse effects were reported among manufacturing plant personnel exposed to 
Bacillus thuringiensis israelensis (Bti).  
Human patch testing with Bacillus thuringiensis subsp.  kurstaki revealed no cases of contact 
hypersensitivity whereas VectoBac (containing Bti AM65-52) was shown to be skin sensitiser in 
guinea pigs (Buehler test). Considering that all microbials should be regarded as potential sensitisers, 
the agreed warning phrase is “Micro-organisms may have the potential to provoke sensitising 
reactions”. 
As mentioned by EFSA in an assessment of Bacillus bacteria with respect to a Qualified Presumption 
of Safety (EFSA, 2007), cases of human illness may have been underreported because of the close Peer review of the pesticide risk assessment of the active substance 
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relationship to the human pathogen Bacillus cereus (Bc). Only the production of insecticidal crystal 
proteins by Bacillus thuringiensis (Bt) distinguishes these two species, and many strains of Bt produce 
the same enterotoxins known from Bc to cause diarrhoea in humans. Additionally, rodents may not be 
the best model for addressing the potential of foodborne poisoning related to the Bacillus cereus type 
toxins (enterotoxins) susceptible to be produced by Bacillus thuringiensis (EFSA, 2008). 
Toxicity studies 
For Bti strain AM65-52, no detailed analysis of the batches used in the toxicological studies is 
available. However, further information can be considered as not required, provided that adequate 
quality control is undertaken on the batches produced, certifying that toxicologically relevant 
pathogenic microbial contaminants are kept below levels internationally recognised for microbial 
contaminants (see data gap in section 1).  
No information has been provided on the potential transfer of genetic material from Bti to other 
organisms. Data or assessment to demonstrate that this transfer does not occur or in case of occurring 
will not lead to adverse effects has to be provided. 
Most of the available acute toxicity studies were performed with VectoBac preparations (containing 
Bacillus thuringiensis subsp. israelensis AM65-52). No adverse effects were observed in rats after 
acute oral exposure and the clearance was complete after 21 days. After intratracheal administration, 
the observed clinical signs and lung lesions were attributed to the presence of foreign material rather 
than to infectivity or pathogenicity of the microbial. After intravenous or intraperitoneal exposure, no 
signs of toxicity were observed. No systemic adverse effects were observed in rabbits after dermal 
exposure, whereas a mild skin and eye irritation was reported.  
Considering that no validated method for genotoxicity testing of microorganisms is available, the need 
for further assessment will have to be considered if human exposure to toxins cannot be excluded. 
Therefore, a data gap has been identified for an assessment of the production of toxins after 
application: enterotoxins (B. cereus type: haemolytic, non haemolytic or cytotoxic), beta-exotoxin 
(ATP analogue), cytolytic proteins (parasporins acting in combination with insecticidal crystal 
proteins). 
The available short term studies were performed with the preparation VectoBac 12 AS (of unknown 
composition). In a 14-day inhalation study (nose-only, 4h/day), no adverse effect was observed in the 
rats administered 1.84x10
6 spores/L. In a 90-day dog study (oral gavage), the NOAEL was 5x10
6 
spores/animal in the absence of treatment-related adverse effect. A justification has to be provided for 
the bridging of these toxicological data towards the representative formulation VectoBac WDG ABG-
6511 (data gap). 
Reference values 
The derivation of reference values was not considered needed since the micro-organism was not 
shown to be pathogenic or infective based on the available data and studies.  
It is noted that there is a potential of food borne poisoning, related to the Bacillus cereus type toxins 
(enterotoxins) susceptible to be produced by Bacillus thuringiensis subsp. israelensis. In most 
instances, food borne diseases caused by Bacillus cereus were associated with the intake of 10
5 to 10
8 
CFU/g food, whereas lower numbers were reported in some outbreaks (10
3 to 10
4 CFU/g food).  
Exposure estimates 
Since reference values are not necessary, no exposure estimates are required for the microorganism. 
Due to the data gap for analysis of the potential toxins (e.g. enterotoxins, beta-exotoxin, cytolytic 
protein) produced after application, the risk assessment cannot be finalised for the re-entry workers. 
 Peer review of the pesticide risk assessment of the active substance 
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3.  Residues 
The only use for this organism is on ornamentals and no edible crops will be treated, therefore a 
consumer risk assessment is not necessary. 
4.  Environmental fate and behaviour 
4.1.  Fate and behaviour in the environment of the microorganism 
Only a review summary of six scientific literature studies has been presented in the dossier. The 
original papers quoted there have not being made available in the dossier. Therefore, a data gap for 
scientific literature quoted by the applicant in its assessment has been identified.  
No information has been provided in relation to potential interferences of Bacillus thuringiensis with 
the analytical systems for the control of the quality of drinking water provided for in Directive 
98/83/EC (See specific Annex VI decision making criteria in Directive 2005/25/EC) (data gap). 
No information has been provided on the potential transfer of genetic material from Bacillus 
thuringiensis to other organisms. However, bacilli are known to have the capacity to transfer genetic 
material trough exchange of plasmids. Therefore, data or assessment to demonstrate that this transfer 
does not occur or in case of occurring will not lead to unacceptable effects on the environment has to 
be provided (See specific Annex VI decision making criteria in Directive 2005/25/EC) (data gap). 
No studies on persistence and multiplication in soil of Bacillus thuringiensis subsp. israelensis strain 
AM65-52 are available. Assessment presented in the DARs is based on the scientific publications 
summarized by the applicant in the dossier on other strains and or species of the Bacillus 
thuringiensis. The experts in the M03 meeting agreed using non strain specific data is acceptable if a 
worst case end point is selected among the data available over a range of strains. During the peer 
review a number of issues have been considered to require further clarification or data. 
According the information provided by the applicant, vegetative cells are not expected to occur in the 
marketed products of Bacillus thuringiensis subsp. israelensis strain AM65-52. Vegetative cells are 
expected to survive and multiply in soil and dead insect cadavers under favourable conditions. The 
persistence and multiplication of vegetative cells in soil is assumed to occur only under a narrow range 
of favourable conditions and limited in time. However, details on the soils and experimental 
conditions used as well as on the individual measurements performed would be needed to allow 
predicting the distribution fate and behaviour in soil of the microorganism and the time courses 
involved.  
Spores are one of the main active components of the marketed products of Bacillus thuringiensis 
subsp. israelensis strain AM65-52. Spores are formed by sporulation and lysis of vegetative cells. 
Spores do not multiply but may remain in a latent form for long periods under a variety of 
environmental conditions. Available data suggest that spores may remain in soil from months to years 
under field conditions. It is believed that exposure to light (UV and visible) is the factor more strongly 
affecting its persistence. Exposure to light may be very variable depending on the mode of application 
and agricultural practices. An estimation of background levels of spores and the time needed to 
recover this level after application of Bacillus thuringiensis subsp. israelensis  strain AM65-52 is 
currently not available.  
PEC soil values presented in the DARs were not agreed during the peer review, since interception 
factors calculated for chemicals are not necessary applicable to microorganisms. RMS was requested 
to provide new PEC soil based assuming no interception (see open point 8.10). This has been 
calculated and may be found in the corresponding appendix.  
No studies on persistence and multiplication in water of Bacillus thuringiensis subsp. israelensis 
strain AM65-52 are available. Assessment presented in the DAR is based on the summary of scientific Peer review of the pesticide risk assessment of the active substance 
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publications submitted by the applicant in the dossier on other strains and or species of the Bacillus 
thuringiensis. However, no individual assessment of the publications was presented in the DAR, so it 
is difficult to track back the statements and conclusions to the original scientific data. The experts at 
PRAPeR meeting M3 agreed that no further data would be needed if the aquatic risk assessment could 
be finalised using an annual total dose PECSW. PECsurface water calculations provided in Addendum 
Appendix 3 were not appropriate as they used field spray drift. Therefore, EFSA performed new PEC 
in surface water for the envisaged greenhouse use. The results can be found in Appendix A. 
4.2.  Fate and behaviour in the environment of any relevant metabolite formed by the 
microorganism under relevant environmental conditions 
Crystalline proteins ( endotoxins) are produced at the time of sporulation. They are exogenous 
metabolites of Bacillus thuringiensis with insecticide activity. These proteins are multicomponent 
proteins that are disaggregated on the single active components (Cry toxins) under favourable 
conditions. The production of this kind of proteins is the common characteristics of all Bacillus 
thuringiensis species. However, the actual proteins may vary from species to species and among 
different strains. The variations usually result in proteins selective to different kind of insects. Bacillus 
thuringiensis subsp. israelensis strain AM65-52 / VectoBac WG crystalline proteins are recognised to 
be relatively selective to: dipterans. These proteins are: 
-  Stable outside the micro organism 
-  Biologically active independently of the presence of the microorganism 
-  Intended to be applied at levels above background levels 
Therefore, the data requirements and the corresponding risk assessment, according directive 
91/414/EEC annex II part A point 7 (standard data requirements and assessment mandatory for 
chemical plant protections active substances), need to be fulfilled and performed for the Bacillus 
thuringiensis crystalline proteins.  
No studies on the route and rate of degradation in soil, mobility in soil and degradation in water 
and water sediment of Bacillus thuringiensis subsp. israelensis strain AM65-52 crystalline proteins 
are available in the dossier. The assessment presented in the DAR is based on the summary of 
scientific publications submitted by the applicant in the dossier on other strains and or species of the 
Bacillus thuringiensis. The waiver based on the consideration of these proteins as pro toxins (that are 
only disaggregated in the toxic proteins in the gut of the insect) was not considered acceptable during 
the peer review, since there is evidence that the toxins can be released under naturally occurring 
environmental conditions outside the target organisms. Furthermore, it is common to many chemically 
synthetic pesticides, that the biologically active moiety is only formed through an enzymatic 
transformation within the target organism. This has never been considered as a justified reason to 
waive environmental exposure assessment, since it is regarded as part of the mechanism of action of 
the precursor pesticide. In the DAR it was stated that the persistence of the parasporal crystal proteins 
is expected to be short. However, no individual assessment of the publications was presented, so it is 
difficult to track back the statements and conclusions to the original scientific data. Worst case 
estimations of soil and water halve lives and soil adsorption would be needed to finalise the 
environment exposure assessment of these proteins. Potential contamination of groundwater is not 
addressed in the dossier. The experts at the PRAPeR meeting M3 identified a data gap for the 
groundwater exposure assessment for the crystal protein and conversion products that retain any 
insecticidal activity to be addressed. In the case of Bacillus thuringiensis subsp. israelensis strain 
AM65-52, only uses in greenhouse on potted plants are intended. Adequate management to prevent 
natural soil and groundwater contamination may be proposed in absence of further information.  
Experimental information on the persistence of the crystal protein in surface water is not addressed in 
the DAR. The experts at PRAPeR meeting M3 agreed that no further data would be needed if the 
aquatic risk assessment could be finalised using an annual total dose PECSW. These have been Peer review of the pesticide risk assessment of the active substance 
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recalculated by EFSA and can be found in Appendix A. However this assessment only covers 
volatilization / deposition route, management measures tailored to local practice and legislation may 
need to be put in place to control the waste disposal of spent application solution and prevent 
accidental spillage entering sewers or surface water drains. 
5.  Ecotoxicology 
It is noted that a data gap for the relevant metabolites was identified in the sections 2 and 4. Pending 
on this data gap, further information to address the ecotoxicological risk assessment for the aquatic 
organisms and soil organisms is required.  
Some strain specific ecotoxicological studies to address the toxicity, infectiveness or pathogenicity of 
Bacillus thuringiensis subsp. israelensis strain AM65-52 on non-target organisms were available.  
Regarding the aquatic organisms, some acute and chronic toxicity studies on fish and daphnids were 
available. A low risk from pathogenicity and infectiveness was indicated. Since the exposure to 
surface waters could not be excluded for the representative use in glasshouses (see fate and behaviour 
section) an aquatic risk assessment was carried out in the Addendum to chapter B.9. The risk for 
aquatic organisms was indicated as low by the TERs for the representative glasshouse use. 
 
A toxicity study on earthworms was provided after the RMS got the dossier.  However, no new studies 
can be taken into account in the peer-review according to Regulation 1095/2007.  
 
Since environmental exposure from the representative use could be considered as negligible, the risk 
for birds, mammals, bees, non-target arthropods other than bees, terrestrial plants were considered as 
low. 
The risk for soil micro organisms was addressed as low, by the available data.  
The exposure of the organisms involved in the biological methods for sewage treatment plants could 
not be excluded, and no study or information was available, a data gap was identified.  
 Peer review of the pesticide risk assessment of the active substance 
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6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental 
compartments 
6.1.  Soil 
Compound 
(name and/or code)  Persistence Ecotoxicology 
Bacillus thuringiensis subsp. israelensis strain AM65-
52 spores. 
No data available. 
May persist months to years in soil 
No data and required. 
Bacillus thuringiensis subsp. israelensis strain AM65-
52 crystalline proteins ( endotoxins).  
No data available.  No data and required. 
6.2.  Ground water 
Compound 
(name and/or code)  Mobility in soil 
>0.1  μg/L 1m depth for 
the representative uses
(at least one FOCUS 
scenario or relevant 
lysimeter) 
Pesticidal activity  Toxicological relevance  Ecotoxicological activity 
Bacillus thuringiensis 
subsp.  israelensis  strain 
AM65-52 crystalline 
proteins ( endotoxins).  
No data available. 
No data available. Data 
gap or proposal for 
management of soil 
residues to avoid 
groundwater 
contamination.  
No data. Not needed  Yes  Low risk  was indentified 
for the aquatic organisms.  
6.3.  Surface water and sediment 
Compound 
(name and/or code)  Ecotoxicology Peer review of the pesticide risk assessment of the active substance 
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Bacillus thuringiensis subsp. israelensis strain AM65-
52 spores.  Low risk was indentified for the aquatic organisms 
Bacillus thuringiensis subsp. israelensis strain AM65-
52 crystalline proteins ( endotoxins).  
No data and not required. 
6.4.  Air 
Compound 
(name and/or code)  Toxicology 
Bacillus thuringiensis subsp. israelensis strain AM65-
52 spores.  No adverse effect after intratracheal instillation of 8x10
7 cfu/rat. 
Bacillus thuringiensis subsp. israelensis strain AM65-
52 crystalline proteins ( endotoxins).  
No data available. 
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7.  List of studies to be generated, still ongoing or available but not peer reviewed 
This is a complete list of the data gaps identified during the peer review process, including those areas 
where a study may have been made available during the peer review process but not considered for 
procedural reasons (without prejudice to the provisions of Article 7 of Directive 91/414/EEC 
concerning information on potentially harmful effects). 
  Validation of the method for protein content (parasporal body protein) (relevant for all 
representative uses evaluated; submission date proposed by the notifier: unknown; see section 1) 
  Method for the unequivocal identification to strain level (relevant for all representative uses 
evaluated; submission date proposed by the notifier: unknown; see section 1) 
  Demonstrate that the level of microbial contamination complies with international standards. The 
OECD issues paper (OECD, 2011) should be used as the reference. This should include analysis 
of batches for IU, CFU and protoxin levels (relevant for all representative uses evaluated; 
submission date proposed by the notifiers: unknown; see section 1). 
  Validation of the methods of analysis for contaminating microorganisms (relevant for all 
representative uses evaluated; submission date proposed by the notifier: unknown; see section 1) 
  Method to detect, isolate and enumerate the microorganism must be validated (relevant for all 
representative uses evaluated; submission date proposed by the notifier: unknown; see section 1) 
  The biopotency method must be validated (relevant for all representative uses evaluated; 
submission date proposed by the notifier: unknown; see section 1) 
  Optimal environmental growing conditions and the temperature range at which the organism 
grows is required for this strain (relevant for all representative uses evaluated; submission date 
proposed by the notifier: unknown; see section 1) 
  Validation data for the methods of analysis for beta-exotoxin and enterotoxin (relevant for all 
representative uses evaluated; submission date proposed by the notifier: unknown; see section 1) 
  Validated method for the CFU in the formulation (relevant for all representative uses evaluated; 
submission date proposed by the notifier: unknown; see section 1) 
  Validation of the bridging of toxicological data between the formulation VectoBac 12 AS 
(detailed composition to be provided) and the representative formulation VectoBac WG (relevant 
for all representative uses evaluated; submission data proposed by the notifier: unknown; see 
section 2).    
 
  Assessment of the production of toxins/secondary metabolites (e.g. enterotoxins, beta-exotoxin, 
cytolytic protein) after application and re-entry worker exposure is missing (relevant for all 
representative uses; submission data proposed by the notifier: unknown; see section 2 ). 
  A data gap has been identified for scientific literature quoted by the applicant in its assessment of 
the fate and behaviour into the environment are not available in the dossiers submitted to RMS 
and EFSA (relevant for all representative uses evaluated; submission date proposed by the notifier: 
no date proposed; see section 4). 
  No information has been provided in relation to potential interferences of Bacillus thuringiensis 
with the analytical systems for the control of the quality of drinking water provided for in 
Directive 98/83/EC (relevant for all representative uses evaluated; submission date proposed by 
the notifier: no date proposed; see section 4) Peer review of the pesticide risk assessment of the active substance 
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  No information has been provided on the potential transfer of genetic material from Bacillus 
thuringiensis to other organisms. (relevant for all representative uses evaluated; submission date 
proposed by the notifier: no date proposed; see section 2 and 4) 
  A data gap has been identified to demonstrate that, under the conditions of use, Bacillus 
thuringiensis subsp. israelensis strain AM65-52 crystalline proteins ( endotoxins) or any of their 
transformation products retaining insecticidal activity will not contaminate ground water above the 
regulatory limit of 0.1 µg /L. Further data on the persistence, transformation and mobility of  
endotoxins may be needed in order to fulfil this data gap. Alternatively a proposal for management 
measures to avoid the groundwater contamination after disposal residues of soil used in 
greenhouse (relevant for all representative uses evaluated; submission date proposed by the 
notifier: no submission date provided; see section 4) 
  Pending on data gap identified in sections 2 and 4, further information to address the 
ecotoxicological risk assessment for the aquatic organisms and soil organisms. (relevant for all 
representative uses evaluated; submission date proposed by the notifier: no submission date 
provided; see section 5) 
  The exposure of the organisms involved in the biological-methods for sewage treatment plants 
could not be excluded, (relevant for all representative uses evaluated; submission date proposed by 
the notifier: no submission date provided; see section 5) 
 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified 
  Aquatic environmental risk assessment available assumes exposure arising from representative 
uses in green house and emissions trough volatilisation and short range transport to surface water. 
However, management measures tailored to local practice and legislation may need to be put in 
place to control the waste disposal of spent application solution and prevent accidental spillage 
entering sewers or surface water drains. Potential for ground water contamination may also be 
addressed with adequate management and disposal of the soil/substrate used in the treated pots 
(see section 4). 
9.  Concerns 
9.1.  Issues that could not be finalised 
An issue is listed as an issue that could not be finalised where there is not enough information 
available to perform an assessment, even at the lowest tier level, for the representative uses in line 
with the Uniform Principles of Annex VI to Directive 91/414/EEC and where the issue is of such 
importance that it could, when finalised, become a concern (which would also be listed as a critical 
area of concern if it is of relevance to all representative uses). 
1.  Pending on their potential exposure to toxins produced after application, the risk assessment 
cannot be finalised for the re-entry workers. 
2.  No information has been provided in relation to potential interferences of Bacillus thuringiensis 
with the analytical systems for the control of the quality of drinking water provided for in 
Directive 98/83/EC. 
3.   Assessment of potential transfer of genetic material cannot be finalised.  
4.  The risk for the organisms involved in the biological methods for sewage treatment plants.  Peer review of the pesticide risk assessment of the active substance 
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9.2.  Critical areas of concern 
An issue is listed as a critical area of concern where there is enough information available to perform 
an assessment for the representative uses in line with the Uniform Principles of Annex VI to Directive 
91/414/EEC, and where this assessment does not permit to conclude that for at least one of the 
representative uses it may be expected that a plant protection product containing the active substance 
will not have any harmful effect on human or animal health or on groundwater or any unacceptable 
influence on the environment.   
An issue is also listed as a critical area of concern where the assessment at a higher tier level could not 
be finalised due to a lack of information, and where the assessment performed at the lower tier level 
does not permit to conclude that for at least one of the representative uses it may be expected that a 
plant protection product containing the active substance will not have any harmful effect on human or 
animal health or on groundwater or any unacceptable influence on the environment. 
  None. 
 
9.3.  Overview of the concerns identified for each representative use considered 
(If a particular condition proposed to be taken into account to manage an identified risk, as listed in 
section 8, has been evaluated as being effective, then ‘risk identified’ is not indicated in this table.) 
 
Representative use  Ornamentals 
(G) 
Operator risk 
Risk 
identified   
Assessment 
not finalised   
Worker risk 
Risk 
identified   
Assessment 
not finalised  X
1 
Bystander risk 
Risk 
identified   
Assessment 
not finalised   
Consumer risk 
Risk 
identified   
Assessment 
not finalised   
Risk to wild non 
target terrestrial 
vertebrates 
Risk 
identified   
Assessment 
not finalised   
Risk to wild non 
target terrestrial 
organisms other 
than vertebrates 
Risk 
identified   
Assessment 
not finalised   
Risk to aquatic 
organisms 
Risk 
identified   
Assessment 
not finalised  X
4 Peer review of the pesticide risk assessment of the active substance 
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Groundwater 
exposure active 
substance 
Legal 
parametric 
value 
breached 
 
Assessment 
not finalised  X
2 
Groundwater 
exposure 
metabolites 
Legal 
parametric 
value 
breached 
 
Parametric 
value of 
10µg/L
(a) 
breached 
 
Assessment 
not finalised   
Comments/Remarks  
The superscript numbers in this table relate to the numbered points indicated in sections 9.1 and 9.2.  Where there is no 
superscript number see sections 2 to 6 for further information. 
(a):  Value for non-relevant metabolites prescribed in SANCO/221/2000-rev 10-final, European Commission, 2003. 
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APPENDICES 
APPENDIX A – LIST OF END POINTS FOR THE ACTIVE SUBSTANCE AND THE REPRESENTATIVE 
FORMULATION 
Chapter 1  Identity, Biological properties, Details of Uses, Further Information 
Active micro-organism:  Bacillus thuringiensis subspecies israelensis, 
(Serotype H-14), Strain AM65-52. 
Function:   Insecticide 
Country to which application is made:  Italy. 
 
Identity of the Microbial Pest control Agent (MPCA) (OECD data point IIM 1) 
Name of the organism:  Bacillus thuringiensis subspecies israelensis, 
(Serotype H-14), Strain AM65-52. 
Taxonomy:  Bacillus thuringiensis subsp israelensis, 
seropytpe H-14, strain AM 65-52 is a 
facultative anaerobic, gram-positive bacterium 
that forms characteristic protein inclusions 
adjacent to the endospore.  The basic 
phenotypic toxin is the subspecies, identified by 
flagella (H) serotype. 
Species, subspecies, strain:  Bacillus thuringiensis subspecies israelensis, 
(Serotype H-14), Strain AM65-52. 
Identification/detection:   Open for validated strain specific method. 
Culture collection:  American Type Culture Collection no. ATCC - 
1276 
Minimum and maximum concentration of the MPCA 
used for manufacturing of the formulated product: 
Bti (Strain AM65-52) technical grade contains 
high and low limits of 20% and 8%, 
respectively of Bacillus thuringiensis subsp. 
israelensis solids, spores and insecticidal 
toxins. 
Identity and content of relevant impurities, additives, 
contaminating organisms in the technical grade of 
MPCA: 
Open for contaminating microorganisms. 
Is the MPCA genetically modified if so provide type 
of modification: 
No 
 Peer review of the pesticide risk assessment of the active substance 
Bacillus thuringiensis israelensis AM65-52
 
EFSA Journal 2013;11(4):3054    20
Biological properties of the micro-organism (OECD data point IIM 2) 
Origin and natural occurrence:  Bacillus thuringiensis subsp israelensis is a 
naturally occurring micro-organism first described 
by de Barjac (1978). 
Background level:  Bacillus thuringiensis subsp israelensis occurs 
ubiquitously at low levels in soil and on plants and 
insects. 
Target organism (s)  Larvae of fungus gnats (Diptera sciaridae). 
Mode of action:  The mode of action of Bti (Strain AM65-52) 
results from toxic proteins contained in parasporal 
crystals.  The crystals are taken up via ingestion 
and under the alkali conditions present in the larvae 
gut the crystal dissolves releasing the active protein 
delta endotoxins that induce disintegration of the 
larvae gut epithelium and consequent death of the 
larvae. 
Host specificity:  Bti (Strain AM65-52) exhibits specific toxicity to 
Dipteran insects upon ingestion. 
Life cycle:  The life-cycle of Bti (Strain AM65-52) follows the 
characteristic process of spore formation 
(sporulation) typical of Bacillus cultures, with the 
exception that insect toxin containing parasporal 
bodies are formed during sporulation. 
Infectivity, dispersal and colonisation ability:  See sections 2, 4, 5. 
Relationships to known plant animal and human 
pathogens: 
Bacillus thuringiensis is related to known human 
pathogens Bacillus anthracis and Bacillus cereus 
that form toxic metabolites.  
 
 
 
 
 
Genetic stability:  Open;  see sections 2 and 4. 
Information on the production of relevant metabolites 
(especially toxins): 
The mode of action of Bti (Strain AM65-52) 
results from toxic proteins contained in parasporal 
crystals.  There are no other active metabolites and 
degradation products that are known to contribute 
to the toxicity of Bti (Strain AM65-52).  The 
presence of beta-exotoxins and enterotoxins which 
may be produced by other Bacillus thuringiensis 
subspecies is monitored and controlled during the 
manufacturing process and do not occur in Bti 
Strain AM65-52. However it is not known if this 
strain can produce the enterotoxin in the human 
gut. 
Resistance/sensitivity to antibiotics/anti-microbial agents 
used in human or veterinary medicine: 
Bti (Strain AM65-52) is susceptible to gentamicin, 
kanamycin, erythromycin, clindamycin, 
vancomycin, chloramphenicol and 
trimethoprim/sulphamethoxazole, but is resistant 
to penicillin, ampicillin and cephalothrin. 
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Classification and proposed labelling 
With regard to physical/chemical data:  Not classified 
With regard to toxicological data:  Not classified 
With regard to fate and behaviour data:  Not classified 
With regard to ecotoxicological data:  Not classified Peer review of the pesticide risk assessment of the active substance 
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Summary of intended uses 
Crop and 
/or 
situation 
Member state 
or Country 
Product 
name 
F 
G 
or 
Pest or 
Group of 
pests 
controlled 
Formulation* Application**  Application rate per treatment 
PHI  
(days) 
Remarks 
(a)     I   
(b) 
(c) Type 
(d-f) 
Conc. of 
as (i) 
Method 
Kind  
(f-h) 
Growth stage & 
season (j) 
Number 
min  max 
Interval 
between 
applications 
(min) 
kg ai/hl 
g ai/m
2 
 
min  max 
water l/ha 
 
min  max 
kg ai/ha 
 
min  max 
(l) (m) 
Orname
ntal (pot 
plants) 
Indoor/all 
EU 
regions 
VectoBac 
(Gnatrol) 
I  Sciarid 
flies 
(fungus 
gnat) 
WG  37.4%  Spray  _  1-3  8-10 days 3 Kg/hl 
 
1000 
L/ha or 
0.1 L/m
2 
3 g ai/m
2  NA  _ 
 
(a)  For crops, the EU and Codex classifications (both) should be used; where relevant, the use situation should be described (e.g. fumigation of a structure) 
(b)  Outdoor or field use (F), glasshouse application (G) or indoor application (I) 
(c)  e.g. biting and suckling insects, soil born insects, foliar fungi, weeds 
(d)  e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
(e)  GCPF Codes - GIFAP Technical Monograph No 2, 1989 
(f)  All abbreviations used must be explained 
(g)  Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench 
(h)  Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plant - type of equipment used must be indicated 
(i)  Cfu=colony forming units and g/kg or g/l 
(j)  Growth stage at last treatment (BBCH Monograph, Growth Stages of Plants,  1997, Blackwell, ISBN 3-8263-3152-4), including where relevant, information on season at time of application 
(k)  Indicate the minimum and maximum number of application possible under practical conditions  of use 
(l)  PHI - minimum pre-harvest interval 
(m)  Remarks may include: Extent of use/economic importance/restrictions 
 
NA = Not applicable.  Product is applied to ornamental crops only and a PHI is not appropriate for this use. 
*    Formulation contains 37.4% by weight Bacillus thuringiensis, subsp. israelensis, strain AM 65-52 fermentation solids and solubles. 
** The product should be applied by spray over the pot plants at a volume of 1000 litres/ha, or 0.1 litre/m
2 on a moving platform.  Sufficient spray should be applied to drench the substrate. 
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Further information 
Production control   Microbiological and biochemical tests are performed to determine the content of 
impurities, biopotency and absence of toxic metabolites 
 
Proposal for classification and 
labelling  
Warning phrase: “Microorganisms may have the potential to provoke sensitising 
reactions.” Peer review of the pesticide risk assessment of the active substance 
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Chapter 2  Analytical Methods  
Analytical methods for the micro-organism  
Manufactured micro-organism (principle of the method):  Open 
Impurities and contaminating micro-organisms in 
manufactured material (principle of method: 
Open for methods for toxins and contaminating 
microorganisms. 
Microbial Pest Control Product (principle of the 
method): 
Open 
 
Analytical methods for residues (viable and non-viable) in exposed compartments and organisms OECD 
data point IIM 4.5) 
Residues of the active micro-organism (principle of the 
method): 
Subject to the outcome of the environmental 
assessment. 
Residues of relevant metabolites (principle of the 
method): 
Not applicable. Peer review of the pesticide risk assessment of the active substance 
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Chapter 3  Effects on Human Health 
Medical data, surveillance and 
observations: 
 
No evidence of adverse health effect among manufacturing plant 
personnel exposed to Bacillus thuringiensis israelensis (Bti). 
Few incidences of adverse effects associated with Bacillus thuringiensis 
exposure are reported in the literature.  
No major effects were observed in populations exposed to aerial 
spraying of Bacillus thuringiensis kurstaki.  
 
Sensitisation: 
 
Human patch testing with Bacillus thuringiensis kurstaki  revealed no 
cases of contact hypersensitivity. 
Without evidence of allergic symptoms or infectious diseases, positive 
IgE tests were found among farm workers highly exposed to Bacillus 
thuringiensis israelensis. 
Bti was shown to be skin sensitiser in a Buehler test with guinea pigs.  
Considering that all microbials should be regarded as potential sensitizers, 
the agreed warning phrase is “Micro-organisms may have the potential to 
provoke sensitising reactions”. 
 
Toxicity 
   after acute oral exposure: 
 
- rat LD50 > 5000 mg/kg bw (~5.5 x 10
11 CFU/kg bw) 
-10
8 CFU/animal had no adverse effects on rats 
- 2.0x10
9 CFU/animal did not induce adverse effects in rats. 
   after acute inhalation exposure: 
 
- Intratracheal instillation of 10
8 CFU/rat  resulted in no mortality, the 
observed clinical signs and lung lesions were attributed to the presence of 
foreign material rather than to an infective process     
- Intratracheal instillation of 8x10
7 CFU/rat resulted in no adverse effects. 
- after aerosol exposure of rats (whole body; 2.84 mg/L, i.e. ~3.2x10
8 
CFU/L), no deaths occurred and no clinical signs were observed after day 
1.  
   after acute intravenous exposure:  10
7 CFU/rat induced no treatment related toxic effects. 
   after single intraperitoneal exposure:  No clinical signs of toxicity in mice at doses of 10
6, 10
7 or 10
8 
CFU/animal, no post-mortem examinations. 
Infectivity 
   after acute oral exposure:  Clearance from organs by day 8, clearance from faeces at day 22. 
   after acute inhalation exposure:  - total clearance was incomplete after intratracheal instillation (day 50 
after instillation)  
- no signs of infectious disease     
   after intravenous exposure:  Uncomplete clearance at day 50 in lungs, spleen, liver, lymph nodes 
and kidneys. 
   after intraperitoneal exposure: Clearance  not  investigated. 
Pathogenicity 
   after acute oral exposure:  No indication of pathogenic effects. 
   after acute inhalation exposure:  No indication of pathogenic effects. 
   after intravenous exposure:  No indication of pathogenic effects. 
   after intraperitoneal exposure:  No indication of pathogenic effects. 
 
Genotoxicity:  Standard mutagenicity and genotoxicity assays are not appropriate for Peer review of the pesticide risk assessment of the active substance 
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  many living microorganisms. 
Potential toxins might  need to be further investigated for their genotoxic 
properties. 
Cell culture study: 
 
 This is not applicable to Bacillus thuringiensis which has not been shown 
to replicate in warm-blooded organisms. 
 
Information on short-term toxicity and 
pathogenicity: 
- 90-day dog (oral gavage): NOAEL 5x10
6 spores/animal. No treatment-
related adverse effect was observed (supplementary information) 
- 14-day rat (4h/d, nose-only): NOAEL 1.84x10
6 spores/L. No treatment-
related adverse effect was observed (supplementary information) 
Dermal toxicity:  Dermal LD50 in rabbits >5000 mg/kg bw VectoBac Technical Powder). 
No dermal reaction or adverse effect after application of Bti to abraded 
rabbit skin, or after ocular instillation. 
Bti induced a mild irritation of the skin and the eye in albino rabbits. 
Specific-toxicity, pathogenicity and 
infectivity: 
 
In a range of toxicological studies with Bacillus thuringiensis serotype H-
14, experimental infection of mice, rats, guinea pigs and rabbits was 
attempted by various routes.  Doses of 10
7 to 10
8 CFU/animal in acute 
studies, up to 10
12 CFU/animal in subacute studies, resulted in no adverse 
toxic effects and no signs of virulence or indication of anaphylaxis.  
(supplementary data)  
 
Reference values 
AOEL  Not applicable based on the lack of pathogenicity and infectivity in 
the available data. 
ADI  Not applicable based on the lack of pathogenicity and infectivity in 
the available data. 
 
Exposure scenarios 
Application method  Indoor application on ornamentals 
Operators  Estimation of exposure not required because the product does not 
raise significant toxicological concerns.  
Workers  Estimation of exposure not required because the product does not 
raise significant toxicological concerns.  
Pending on their exposure to toxins potentially produced after 
application, the risk assessment cannot be finalised. 
Bystanders  Estimation of exposure not required because the product does not 
raise significant toxicological concerns.  
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Chapter 4  Residues 
Bti (Strain AM65-52) is recommended for the control of fungus gnats (Sciaridae) in ornamental plant 
cultivation.  Bti (Strain AM65-52) is not infective and is not toxic or pathogenic to mammalian species.  Data on 
potential residues of Bti (Strain AM65-52) in food or feedstuffs are therefore not relevant and it is not considered 
necessary to propose an Acceptable Daily Intake (ADI), calculate the potential exposure of consumers, or 
propose a Maximum Residue Level (MRL) for this MCPA. 
Residues in or on treated products, food and feed  
Viable residues  Not applicable 
Non-viable residues  Not applicable 
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Chapter 5  Fate and Behaviour in the Environment  
Persistence and multiplication in soil  No data on the persistence and multiplication of Bacillus 
thuringiensis subsp. israelensis strain AM65-52 in soil is 
available in the dossier.  
Bacillus thuringiensis occurs naturally and ubiquitously 
in the environment. It is a common component of the soil 
micro-biota and has been isolated from most terrestrial 
habitat. Available information indicates that Bacillus 
thuringiensis spores may persist from months to years in 
soil under natural field conditions. The low potential for 
spore germination, growth and re-sporulation in soils is 
expected to restrict population growth. 
 
Assuming no degradation, following three applications 
of 30 kg MPCA/ha the initial PECsoil values for 
VectoBac WG after the last application are: 
 
PEC soil:  39.1 mg /kg dry weight soil 
  1.9 x 10
9 CFU /kg dry weight soil 
 
However, it should be noted that the intended use is on 
potted plants in greenhouses. Risk management 
measures are expected to be put in place to avoid the 
release of contaminated soil into the environment.  
  
Persistence and multiplication in water an air  No data on the persistence and multiplication of Bacillus 
thuringiensis subsp. israelens strain AM65-52 in aquatic 
environment is available in the dossier.  
According available information, B. thuringiensis is not 
regarded as an autochthonous inhabitant of aquatic 
environments and does not find optimal conditions for 
growth. Therefore, proliferation is not likely to occur.  
 
PECSW in terms of viable spores (cfu) of active 
substance: 
Application rate: 3 x 3 x 10
13 cfu/ha 
Amount reaching the soil: 9 x 10
13 cfu/ha 
Relevant value for spray drift (FOCUS air for indoor 
uses[Focus (2008)]): 0.05 %, resulting in 4.5 x 10
10 cfu 
Amount reaching the water: 4.5 x 10
10 cfu 
Initial PECsw assuming a water volume of 30000 L:  
 
1.5 x 10
4 cfu/l 
 
PECSW  in terms of crystal protein 
Application rate: 3 x 30 kg/ha 
Amount reaching the soil: 90 kg/ha 
Relevant value for spray drift (FOCUS air for indoor 
uses[Focus (2008)]): 0.05 %, resulting in  g 
Amount reaching the water: 45 g 
Initial PECsw assuming a water volume of 30000 L:  
 
15 µg/l 
 
This assessment covers volatilization / deposition route, 
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legislation may need to be put in place to control the 
waste disposal of spent application solution.  
Persistence and multiplication in air  No data available. As for other microbial spores, 
degradation due to solar radiation may be expected. 
Mobility  Spores:  
According available information, it has been concluded 
that movement of Bt spores through the soil by leaching 
is unlikely to occur. 
 
Crystalline proteins (-endotoxins): data gap identified 
to address potential ground water contamination. 
However, in the case of Bacillus thuringiensis subsp. 
israelensis strain AM65-52 only uses in greenhouse on 
potted plants are intended. Adequate management to 
prevent groundwater contamination may be put in place 
in absence of further information. 
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Chapter 6  Effects on Non-target Species  
 
Effects on birds 
Application rate 
(kg MPCA/ha) 
Crop  Category 
(eg insectivorous bird) 
Time-scale  Toxicity, infectivity and 
pathogenicity (endpoint, value or 
other description of effects) 
3 g a.s./m
2  Ornamental 
pot plants 
Mallard duck  Short-term   LC50 >3077 mg/kg per day 
(equivalent to a daily dose of 716 
mg/kg bw/day); LC50 > 6.2 x 10
11 
CFU/g 
3 g a.s./m
2  Ornamental 
pot plants 
Northern bobwhite  Short-term  LC50 >3077 mg/kg per day 
(equivalent to a daily dose of 1874 
mg/kg bw/day); LC50 > 6.2 x 10
11 
CFU/g 
The risk assessment was not needed. 
Effects on aquatic organisms 
Group Test 
substance 
Time-scale  Toxicity, infectivity and pathogenicity (endpoint, 
value or other description of effects) 
Laboratory tests – fish species 
Oncorhynchus 
mykiss 
Bti  Acute  
96-hours 
96h LC50 >370 mg a.s./L 
Lepomis 
macrochirus 
Bti  Acute  
96-hours 
96h LC50 >600 mg a.s./L 
Oncorhynchus 
mykiss 
Vectobac 
technical  
Chronic 
32-day  
NOEC - 1.1x 10
10 CFU/L aqueous exposure; NOEC – 
0.055 g/L 
 
Lepomis 
macrochirus 
Vectobac 
technical  
Chronic 
30-day 
NOEC - 1.2 x 10
10 CFU/L aqueous exposure; NOEC – 
0.06 g/L. 
 
Cyprinodon 
variegatus 
Vectobac 
technical  
Chronic 
30-day 
NOEC - 1.3 x 10
10 CFU/L aqueous exposure; NOEC – 
0.065 g/L  
 
Laboratory tests – invertebrate species 
Daphnia 
magna 
Vectobac 
technical  
Chronic 
10-day 
10-day LC50 - >50 mg a.s./L;  
 
Daphnia 
magna 
Vectobac 
technical  
Chronic 
21-day 
NOEC  = 5 mg a.s./L, NOEC = 1 x 10
9 CFU/L 
Grass shrimp 
(Palaemonetes 
vulgaris) 
Vectobac 
technical  
Chronic 
31-day 
NOEC = 2.0 x 10
10 CFU/g dietary concentration; NOEC 
= 0.1 g MPCA/L 
 
Mayfly nymphs 
(Hexagenia sp) 
Vectobac 
technical  
Chronic 
18-day  NOEC = 2.0 x 10
10 CFU/L aqueous concentration ; 
NOEC = 0.1 g MPCA/L 
 
Amphiascus 
minutus 
Vectobac 
technical  
Chronic 
10-day 
10-day LC50 - >50 mg a.s./L; 10-day LC50 - > 1x10
10 
CFU /L 
NOEC - 50 mg a.s./L; NOEC - 1x10
10 CFU/L 
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Natural 
assemblage of 
aquatic 
invertebrate 
fauna 
VectoBac-G, 
(Bti spores 
and crystals 
associated 
with corn 
cobs) 
Chronic  Repeated application of VectoBac-G (Bacillus 
thuringiensis var. israelensis, Strain AM65-52) did 
not affect density of total insects, Diptera, non-
dipterans, Chironomidae, predators, and non-insect 
benthic invertebrates. Biomass comparisons between 
treatments showed a very similar pattern to the 
density results. 
 
Effects on algae (growth, growth rate, capacity to recover) 
A study with Bti toxins showed that pure Euglena spp, Chlamydomonas sp., Oedogonium sp, mixed algal 
cultures and a cyanobacterium (Oscillatoria sp) were not inhibitory in dilution tests.  
Algae are not considered to be at risk as there is no mechanism for the ingestion of Bti (Strain AM65-52) and 
therefore no appropriate digestive enzymes to enable the release of the active protein delta endotoxins.   
 
Effects on plants other than algae:  
Plants are not considered to be at risk as there is no mechanism for the ingestion of Bti (Strain AM65-52) and 
therefore no appropriate digestive enzymes to enable the release of the active protein delta endotoxins. 
 
Aquatic organisms End-point PECsw TER 
Amphiascus minutus 
10-day LC50 - > 1x10
10 
CFU /L 
1.5 x 10
6 cfu/l 
  9999.9 
 
The risk assessment was not needed. 
 
 
Effects on other arthropods species  
No studies have been conducted on other arthropod species. According to the Applicant this has been 
considered not relevant owing to the use in pot cultures 
However, it has been considered that the ornamental plants are not often grown in pots but in soil under 
greenhouse conditions. Moreover, during spring- summer- and autumn-time frequently the greenhouses are 
opened for most of the time. However, it has to be considered the use of the product on pot soil. 
The risk assessment was not needed. 
 
Effects on earthworms     
Product Species  Not  specified 
Data available were submitted after the 
dossier and they were not considered 
according to the procedure 
  
     
 
Effects on bees     LD50/24h LD50/24h LD50/48h LD50/48h 
(μg product/bee)  (CFU product/bee)  (μg product/bee)  (μg product/bee) 
Oral toxicity test  > 108.04  > 2.16x10
5   > 108.04  > 2.16x10
5  
Contact toxicity test  > 100  > 2x10
5  > 100  > 2x10
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Effects on non-target soil micro-organisms  
A study on the effects on non-target soil micro-organisms has been provided by the Applicant. No bacteriostatic 
or bactericidal activity was detected in the dilution or disk-diffusion assays with the toxins from Bti against the 
various pure and mixed cultures (Bacillus megaterium, B. subtilis, B. cereus, Staphylococcus faecalis, or 
Staphylococcus aureus) regardless of whether the cultures were incubated under starvation or non-starvation 
conditions.  No antibiotic activity of the ICPs from Bti against against the above bacteria were observed.  
 
Additional studies  
Nitrogen mineralisation:  No additional studies were conducted and not 
needed. 
Carbon mineralisation:  No additional studies were conducted and not 
needed. 
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APPENDIX B – USED COMPOUND CODE(S) 
Code/Trivial name*  Chemical name  Structural formula 
---    
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ABBREVIATIONS 
1/n  slope of Freundlich isotherm 
λ wavelength 
  decadic molar extinction coefficient 
°C  degree Celsius (centigrade) 
µg microgram 
µm micrometer  (micron) 
a.s. active  substance 
AChE acetylcholinesterase 
ADE  actual dermal exposure 
ADI  acceptable daily intake 
AF assessment  factor 
AOEL  acceptable operator exposure level 
AP alkaline  phosphatase 
AR applied  radioactivity 
ARfD  acute reference dose 
AST  aspartate aminotransferase (SGOT) 
AV avoidance  factor 
BCF bioconcentration  factor 
BUN  blood urea nitrogen 
bw body  weight 
CAS  Chemical Abstracts Service 
CFU  colony forming units 
ChE cholinesterase 
CI confidence  interval 
CIPAC  Collaborative International Pesticides Analytical Council Limited 
CL confidence  limits 
cm centimetre 
d day 
DAA  days after application 
DAR  draft assessment report 
DAT  days after treatment 
DM dry  matter 
DT50  period required for 50 percent disappearance (define method of estimation) 
DT90  period required for 90 percent disappearance (define method of estimation) 
dw dry  weight 
EbC50  effective concentration (biomass) 
EC50 effective  concentration 
ECHA  European Chemical Agency 
EEC  European Economic Community 
EINECS  European Inventory of Existing Commercial Chemical Substances 
ELINCS  European List of New Chemical Substances 
EMDI  estimated maximum daily intake 
ER50  emergence rate/effective rate, median 
ErC50  effective concentration (growth rate) 
EU European  Union 
EUROPOEM  European Predictive Operator Exposure Model 
f(twa)  time weighted average factor 
FAO  Food and Agriculture Organisation of the United Nations 
fd feed 
FIR  Food intake rate 
FOB  functional observation battery 
FOCUS  Forum for the Co-ordination of Pesticide Fate Models and their Use 
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GAP  good agricultural practice 
GC gas  chromatography 
GCPF  Global Crop Protection Federation (formerly known as GIFAP) 
GGT  gamma glutamyl transferase 
GM geometric  mean 
GS growth  stage 
GSH glutathion 
h hour(s) 
ha hectare 
Hb haemoglobin 
Hct haematocrit 
hL hectolitre 
HPLC  high pressure liquid chromatography  
or high performance liquid chromatography 
HPLC-MS  high pressure liquid chromatography – mass spectrometry 
HQ hazard  quotient 
IEDI  international estimated daily intake 
IESTI  international estimated short-term intake 
ISO  International Organisation for Standardisation 
IU International  Unit 
IUPAC International  Union  of  Pure and Applied Chemistry 
JMPR  Joint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and 
the Environment and the WHO Expert Group on Pesticide Residues (Joint 
Meeting on Pesticide Residues) 
Kdoc  organic carbon linear adsorption coefficient 
kg kilogram 
KFoc  Freundlich organic carbon adsorption coefficient 
L litre 
LC liquid  chromatography 
LC50  lethal concentration, median 
LC-MS  liquid chromatography-mass spectrometry 
LC-MS-MS  liquid chromatography with tandem mass spectrometry 
LD50  lethal dose, median; dosis letalis media 
LDH lactate  dehydrogenase 
LOAEL  lowest observable adverse effect level 
LOD  limit of detection 
LOQ  limit of quantification (determination) 
m metre 
M/L  mixing and loading 
MAF  multiple application factor 
MATC  maximum allowable toxicant concentration 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
mg milligram 
mL millilitre 
mm millimetre 
mN milli-newton 
MPCA  Microbial pest control agent 
MRL  maximum residue limit or level 
MS mass  spectrometry 
MSDS  material safety data sheet 
MTD  maximum tolerated dose 
MWHC  maximum water holding capacity 
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ng nanogram 
NOAEC  no observed adverse effect concentration 
NOAEL  no observed adverse effect level 
NOEC  no observed effect concentration 
NOEL  no observed effect level 
OD oil  dispersion 
OECD  Organisation for Economic Co-operation and Development  
OM  organic matter content 
Pa pascal 
PD  proportion of different food types 
PEC  predicted environmental concentration 
PECair  predicted environmental concentration in air 
PECgw  predicted environmental concentration in ground water 
PECsed  predicted environmental concentration in sediment 
PECsoil  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
pH pH-value 
PHED  pesticide handler's exposure data 
PHI pre-harvest  interval 
PIE  potential inhalation exposure 
pKa  negative logarithm (to the base 10) of the dissociation constant 
Pow  partition coefficient between n-octanol and water 
PPE  personal protective equipment 
ppm  parts per million (10
-6) 
ppp  plant protection product 
PT  proportion of diet obtained in the treated area 
PTT  partial thromboplastin time 
QSAR  quantitative structure-activity relationship 
r
2  coefficient of determination 
REACH  Registration, Evaluation, Authorisation of CHemicals  
RPE  respiratory protective equipment 
RUD  residue per unit dose 
SC suspension  concentrate 
SD standard  deviation 
SFO single  first-order 
SSD species  sensitivity  distribution 
STMR  supervised trials median residue 
t1/2  half-life (define method of estimation) 
TER  toxicity exposure ratio 
TERA  toxicity exposure ratio for acute exposure 
TERLT  toxicity exposure ratio following chronic exposure 
TERST  toxicity exposure ratio following repeated exposure 
TK technical  concentrate 
TLV  threshold limit value 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
TSH  thyroid stimulating hormone (thyrotropin) 
TWA  time weighted average 
UDS unscheduled  DNA  synthesis 
UV ultraviolet 
W/S water/sediment 
w/v  weight per volume 
w/w  weight per weight 
WBC  white blood cell 
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WHO  World Health Organisation 
wk week 
yr year 
 